Recent studies illustrate β1 integrin inhibition enhanced radiosensitivity in HNSCC, mainly impacting on β1 Integrin/FAK/cortactin signaling (Eke et al., 2012a; Eke et al., 2012b). This evidence concerns the gene CTTN and head and neck squamous cell carcinoma.